KA
TNDM icon

Kovack Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Kovack Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,974
Closed -$451K – 658
2020
Q3 		$451K Sell
3,974
-46
-1% -$4.83K 0.08% 244
2020
Q2 		$398K Hold
4,020
– – 0.08% 257
2020
Q1 		$259K Sell
4,020
-110
-3% -$7.71K 0.06% 324
2019
Q4 		$246K Buy
4,130
+392
+10% +$24.2K 0.04% 407
2019
Q3 		$220K Buy
3,738
+102
+3% +$6.51K 0.05% 403
2019
Q2 		$235K Buy
+3,636
New +$235K 0.05% 361

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kovack Advisors's TNDM Position: Q4 2020 in Review

Kovack Advisors sold out of Tandem Diabetes Care (TNDM) in Q4 2020, closing a stake of 3,974 shares — an estimated $451K sold.

Kovack Advisors first reported a position in TNDM in Q2 2019 and held it in 6 quarters. The position peaked at $451K in Q3 2020. 309 funds tracked by Wall St. Rank hold TNDM as of Q4 2020.

  • Kovack Advisors reported no remaining Tandem Diabetes Care position as of Q4 2020 after selling out during the quarter.
  • Kovack Advisors sold 3,974 Tandem Diabetes Care shares in Q4 2020, an estimated $451K.
  • Kovack Advisors first reported a position in Tandem Diabetes Care in Q2 2019 and held it in 6 quarters.
  • Kovack Advisors's Tandem Diabetes Care position peaked at $451K in Q3 2020.
  • 309 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2020.

Based on Kovack Advisors's 13F filing for Q4 2020, filed 14 Jan 2021.